Table 3.
Non-HIV-Infected Below Median EAT Volume (n=13) |
HIV-Infected Below Median EAT Volume (n=27) |
Non-HIV-Infected Above Median EAT Volume (n=14) |
HIV-Infected Above Median EAT Volume (n=28) |
Overall P Value | |
---|---|---|---|---|---|
Markers of Monocyte/Macrophage Activation* | |||||
| |||||
MCP-1, pg/mL | 166 ± 31 | 235 ± 22 | 249 ± 31 | 262 ± 22 | 0.10 |
CXCL10, pg/mL | 131 ± 60 | 285 ± 43 | 179 ± 60 | 305 ± 42 | 0.02a,c,f |
sCD163, ng/mL | 984 ± 237 | 1642 ± 171 | 1506 ± 237 | 1896 ± 167 | 0.004a,c |
sCD14, ng/mL | 1594 ± 406 | 2021 ± 293 | 1310 ± 406 | 2488 ± 287 | 0.03f |
| |||||
Inflammatory Markers* | |||||
| |||||
hsIL6, pg/mL | 1.68 ± 0.32 | 1.56 ± 0.25 | 1.94 ± 0.32 | 2.20 ± 0.24 | 0.32 |
Lp-PLA2, nmol/min/mL | 135 ± 14 | 174 ± 10 | 168 ± 14 | 176 ± 10 | 0.04a,b,c |
| |||||
Plaque Characteristics** | |||||
| |||||
Presence of coronary plaque, % | 23 | 40 | 54 | 33 | 0.41 |
Segments with noncalcified plaque, % | 33 ± 19 [0 (0,100)] | 71 ± 10 [71 (63,100)] | 19 ± 13 [0 (0,44)] | 78 ± 12 [88 (54,100)] | 0.009 (0.047)d,f |
Segments with mixed plaque, % | 13 ± 16 [0 (0,40)] | 27 ± 9 [25 (0,33)] | 51 ± 11 [42 (31,75)] | 17 ± 10 [0 (0,33)] | 0.13 (0.13) |
Segments with calcified plaque, % | 53 ± 14 [60 (0,100)] | 3 ± 8 [0 (0,0)] | 40 ± 9 [33 (0,67)] | 5 ± 9 [0 (0,13)] | 0.003 (0.01)a,c,d,f |
| |||||
Metabolic Parameters | |||||
| |||||
Fasting glucose, mg/dL | 78 ± 10 | 91 ± 7 | 88 ± 10 | 90 ± 7 | 0.75 |
Triglycerides, mg/dL | 85 ± 17 | 113 ± 12 | 134 ± 17 | 104 ± 12 | 0.24 |
Abbreviations: EAT, epicardial adipose tissue; MCP-1, monocyte chemoattractant protein-1; CXCL10, C-X-C motif chemokine 10; sCD163, soluble CD163; sCD14, soluble CD14; hsIL6, high sensitivity interleukin 6; Lp-PLA2, lipoprotein-associated phospholipase A2
Data reported as mean ± standard error; overall P value by ANOVA. Data for markers of monocyte/macrophage activation and generalized inflammation are presented prior to log transformation only for purposes of clinical interpretation; the appropriate statistical test was applied after log-transformation.
For plaque segment data, non-normally distributed data also reported as [median (IQR)]; overall P value by Kruskal-Wallis test.
P < 0.05 Non-HIV-Infected Below Median EAT vs. HIV-Infected Below Median EAT
P < 0.05 Non-HIV-Infected Below Median EAT vs. Non-HIV-Infected Above Median EAT
P < 0.05 Non-HIV-Infected Below Median EAT vs. HIV-Infected Above Median EAT
P < 0.05 HIV-Infected Below Median EAT vs. Non-HIV-Infected Above Median EAT
P < 0.05 HIV-Infected Below Median EAT vs. HIV-Infected Above Median EAT
P < 0.05 Non-HIV-Infected Above Median EAT vs. HIV-Infected Above Median EAT